Triple

T6882817
Position Surface form Disambiguated ID Type / Status
Subject Goody Mob E158839 entity
Predicate notableSong P4 FINISHED
Object Cell Therapy E625146 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Cell Therapy | Statement: [Goody Mob, notableSong, Cell Therapy]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Cell Therapy
Context triple: [Goody Mob, notableSong, Cell Therapy]
  • A. Cell Therapy chosen
    "Cell Therapy" is a socially conscious Southern hip hop track by Goodie Mob, known for its commentary on surveillance, systemic oppression, and life in Atlanta’s inner city.
  • B. Center for Cellular and Molecular Therapeutics
    The Center for Cellular and Molecular Therapeutics is a research institute specializing in developing gene and cell-based therapies for pediatric and genetic diseases.
  • C. Committee on Development, Regeneration and Stem Cell Biology
    The Committee on Development, Regeneration and Stem Cell Biology is an academic program at the University of Chicago focused on research and graduate training in developmental biology, tissue regeneration, and stem cell science.
  • D. Yamanaka factors
    Yamanaka factors are a set of transcription factors that can reprogram adult somatic cells into induced pluripotent stem cells, revolutionizing regenerative medicine and stem cell research.
  • E. Office of Tissues and Advanced Therapies
    The Office of Tissues and Advanced Therapies is a U.S. FDA office responsible for regulating cellular and gene therapies, tissue-based products, and other advanced biologic treatments.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69c688342f6c8190ad7eea6ba262db99 completed March 27, 2026, 1:37 p.m.
NER Named-entity recognition batch_69c6d8e90c9481908d00634f67fa71f8 completed March 27, 2026, 7:22 p.m.
NED1 Entity disambiguation (via context triple) batch_69c748c79d2c819097462b4517dd76d7 completed March 28, 2026, 3:19 a.m.
Created at: March 27, 2026, 2:23 p.m.